Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de valores de Sao Paulo  >  Hypermarcas SA    HYPE3   BRHYPEACNOR0

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Hypermarcas SA : Material Fact - Closing of ASSOLAN, PERFEX and CROSS HATCH selling

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/23/2011 | 10:40pm CET
HYPERMARCAS S.A.

A Publicly-Held Corporation

CNPJ/MF No. 02.932.074/0001-91
NIRE 35.300.353.251

MATERIAL FACT

HYPERMARCAS S.A. (the "Company" or "Hypermarcas") in compliance with the provisions of Article 157, paragraph 4th, of Law No. 6,404, of December 15, 1976, as amended (the "Brazilian Corporate Law"), and of Brazilian Securities and Exchange Commission - CVM Ruling No. 358, of January 3, 2002, as amended, comes to public to inform that, in addition to the Material Fact released by the Company on December
9th, 2011, and upon the implementation and/or fulfillment, as the case may be, of the precedent conditions, set forth in the "Contrato de Compra e Venda de Quotas e Outras Avenças" (Agreement for the Purchase and Sale of Quotas and Other Covenants - the "Agreement"), executed on December 9th, 2011, alienated, to Química Amparo Ltda. ("Química Amparo"), on the date hereof, of the business of manufacturing and sale of steel wool, steel cloth, synthetic sponges, cleaning cloths and scouring powder, distributed under trademarks "ASSOLAN", "PERFEX" and "CROSS HATCH" (the "Household Cleaning Business"), by means of the transfer of quotas representing the entirety of the capital stock of Assolan Holding Ltda., a special purpose entity established by Hypermarcas exclusively for the purpose of contributing the Household Cleaning Business prior to its transfer to Química Amparo.
São Paulo, December 23, 2011

HYPERMARCAS S.A. Breno Toledo Pires de Oliveira Investor Relations Officer - IRO

SP - 2667080v1

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on HYPERMARCAS SA
11/22 COTY INC. (NYSE : COTY) Files An 8-K Completion of Acquisition or Disposition of..
10/25 HYPERMARCAS : Notice to the Market - Change in Fiscal Council
10/25 HYPERMARCAS : Material Fact - Board of Directors and Controlling Group
07/28 HYPERMARCAS SA : ex-dividend day for interim dividend
07/23 HYPERMARCAS : Notice to the Market - Audit Committee
06/28 HYPERMARCAS : Material Fact
05/03DJCoty Swings to a Loss Amid Acquisition Costs
05/03DJCoty Swings to a Loss Amid Acquisition Costs
05/03 HYPERMARCAS SA : ex-dividend day for annual dividend
04/15 HYPERMARCAS SA : ex-dividend day for annual dividend
More news
Sector news : Generic Pharmaceuticals
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Generic Pharmaceuticals
News from SeekingAlpha
2015 Coty acquires Brazilian beauty business
2015 Kimberly-Clark on the hunt for Brazilian diaper business
Advertisement
Financials ( BRL)
Sales 2016 3 292 M
EBIT 2016 1 100 M
Net income 2016 1 329 M
Finance 2016 829 M
Yield 2016 2,00%
P/E ratio 2016 12,05
P/E ratio 2017 16,30
EV / Sales 2016 4,51x
EV / Sales 2017 3,87x
Capitalization 15 680 M
More Financials
Chart HYPERMARCAS SA
Duration : Period :
Hypermarcas SA Technical Analysis Chart | HYPE3 | BRHYPEACNOR0 | 4-Traders
Full-screen chart
Technical analysis trends HYPERMARCAS SA
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 30,6  BRL
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Claudio Bergamo dos Santos Chief Executive Officer & Director
João Alves de Queiroz Filho Chairman
Vivian Karina Trujillo Angiolucci Executive Director-Operations
Martim Prado Mattos Chief Financial Officer
Esteban Malpica Fomperosa Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
HYPERMARCAS SA17.05%4 521
SUN PHARMACEUTICAL IND..-11.92%25 404
OTSUKA HOLDINGS CO LTD3.32%22 196
ONO PHARMACEUTICAL CO...-42.62%13 002
ASPEN PHARMACARE HOLDI..-8.88%9 268
SHANGHAI FOSUN PHARMAC..-1.83%7 929
More Results